|
VPS52 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.766300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.459600E-02 |
| Normal-vs-Stage2 |
1.768390E-01 |
| Normal-vs-Stage3 |
5.466300E-02 |
| Normal-vs-Stage4 |
1.653980E-01 |
| Stage1-vs-Stage2 |
9.473200E-01 |
| Stage1-vs-Stage3 |
5.275800E-01 |
| Stage1-vs-Stage4 |
8.654200E-01 |
| Stage2-vs-Stage3 |
6.031200E-01 |
| Stage2-vs-Stage4 |
8.319400E-01 |
| Stage3-vs-Stage4 |
8.248400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.240200E-02 |
| Normal-vs-AfricanAmerican |
1.053430E-01 |
| Normal-vs-Asian |
3.646700000004E-05 |
| Caucasian-vs-AfricanAmerican |
9.220600E-01 |
| Caucasian-vs-Asian |
5.644200E-04 |
| AfricanAmerican-vs-Asian |
2.123600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.525700E-02 |
| Normal-vs-Female |
3.097800E-01 |
| Male-vs-Female |
2.261400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.320970E-01 |
| Normal-vs-Extreme_Weight |
3.582000E-02 |
| Normal-vs-Obese |
3.221800E-01 |
| Normal-vs-Extreme_Obese |
6.079700E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.603800E-01 |
| Normal_Weight-vs-Obese |
6.153400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.455200E-01 |
| Extreme_Weight-vs-Obese |
1.881770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.738600E-01 |
| Obese-vs-Extreme_Obese |
3.651800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.213200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.598200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.105900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.058100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.423000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.631800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.578100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.598200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.278400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.376360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.457600E-01 |
| Normal-VS-Type2 PRCC |
1.363290E-03 |
| Normal-VS-KIRP CIMP |
3.855600E-03 |
| Normal-VS-Unclassified PRCC |
1.932590E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.031500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.137000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.564400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.041800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.580400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.098240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.244400E-04 |
| Normal-vs-N1 |
9.306400E-02 |
| Normal-vs-N2 |
1.943860E-02 |
| N0-vs-N1 |
3.773000E-01 |
| N0-vs-N2 |
2.533000E-01 |
| N1-vs-N2 |
2.441000E-01 |
|
|
